Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6767

TDMS Study 05188-05 Pathology Tables

NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96
Route: SKIN APPLICATION                                                                                           Time: 04:28:15




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  1300-72-7

       Lock Date:  07/13/93

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All




































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                14           10           15           12                                     
    Natural Death                                     13           24           18           22                                     
    Accidently Killed                                  1                                                                            
  Survivors                                                                                                                         
    Terminal Sacrifice                                22           15           17           16                                     
    Natural Death                                                   1                                                               

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (50)         (35)         (33)         (50)                                   
      Parasite Metazoan                                2 (4%)       1 (3%)                    3 (6%)                                
   Intestine Large, Rectum                            (50)         (35)         (33)         (50)                                   
      Parasite Metazoan                                4 (8%)       3 (9%)       1 (3%)       3 (6%)                                
   Intestine Large, Cecum                             (50)         (35)         (33)         (50)                                   
      Inflammation, Chronic Active                                  1 (3%)       1 (3%)       1 (2%)                                
      Ulcer                                                         1 (3%)                                                          
   Intestine Small, Duodenum                          (50)         (35)         (33)         (50)                                   
      Inflammation, Chronic Active                                               1 (3%)                                             
      Ulcer                                            1 (2%)                    1 (3%)                                             
   Liver                                              (50)         (35)         (33)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Basophilic Focus                                30 (60%)     12 (34%)     11 (33%)     26 (52%)                               
      Clear Cell Focus                                 1 (2%)                                 1 (2%)                                
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hepatodiaphragmatic Nodule                      10 (20%)      6 (17%)     11 (33%)      3 (6%)                                
      Inflammation, Chronic                           21 (42%)     17 (49%)     19 (58%)     24 (48%)                               
      Mixed Cell Focus                                                                        1 (2%)                                
      Necrosis                                         3 (6%)       1 (3%)       3 (9%)       3 (6%)                                
      Pigmentation, Hemosiderin                        3 (6%)       1 (3%)                                                          
      Pigmentation, Melanin                            1 (2%)                                                                       
      Bile Duct, Hyperplasia                          28 (56%)     13 (37%)     17 (52%)     21 (42%)                               
      Central Vein, Thrombosis                         1 (2%)                                                                       
      Hepatocyte, Hyperplasia                          2 (4%)                    1 (3%)       1 (2%)                                
      Hepatocyte, Vacuolization Cytoplasmic           15 (30%)                   4 (12%)      4 (8%)                                
      Hepatocyte, Centrilobular, Degeneration,                                                                                      
           Fatty                                       4 (8%)       1 (3%)       3 (9%)       2 (4%)                                
      Portal Vein, Thrombosis                                                                 1 (2%)                                
   Mesentery                                          (2)          (4)          (4)          (4)                                    
      Mineralization                                   1 (50%)                   2 (50%)      1 (25%)                               
      Artery, Inflammation, Chronic Active                          1 (25%)                                                         
      Fat, Inflammation, Chronic Active                1 (50%)      2 (50%)      1 (25%)      2 (50%)                               

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Necrosis                                    1 (50%)                   2 (50%)                                            
   Oral Mucosa                                        (1)                                    (2)                                    
      Gingival, Inflammation, Chronic Active                                                  2 (100%)                              
   Pancreas                                           (50)         (35)         (33)         (50)                                   
      Cyst                                                                       1 (3%)                                             
      Hypertrophy, Focal                                                                      1 (2%)                                
      Inflammation, Chronic Active                                  1 (3%)       1 (3%)                                             
      Acinus, Atrophy                                 12 (24%)      3 (9%)       5 (15%)      8 (16%)                               
      Artery, Inflammation, Chronic Active             1 (2%)                                 1 (2%)                                
   Stomach, Forestomach                               (50)         (35)         (33)         (50)                                   
      Inflammation, Chronic Active                     2 (4%)       4 (11%)      3 (9%)       4 (8%)                                
      Ulcer                                            2 (4%)       2 (6%)       3 (9%)       3 (6%)                                
      Epithelium, Hyperplasia                          2 (4%)       4 (11%)      3 (9%)       5 (10%)                               
   Stomach, Glandular                                 (50)         (35)         (33)         (50)                                   
      Inflammation, Chronic Active                                  1 (3%)       1 (3%)                                             
      Mineralization                                   1 (2%)                    1 (3%)                                             
      Necrosis                                         1 (2%)       1 (3%)                                                          
      Ulcer                                                                      1 (3%)                                             
      Epithelium, Erosion                              1 (2%)       1 (3%)                                                          
      Epithelium, Hemorrhage                           1 (2%)                                                                       
      Epithelium, Necrosis                             1 (2%)                                                                       
   Tooth                                              (1)                                    (1)                                    
      Inflammation                                                                            1 (100%)                              
      Peridontal Tissue, Inflammation, Chronic                                                                                      
          Active                                       1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (35)         (33)         (50)                                   
      Mineralization                                   1 (2%)                    1 (3%)                                             
   Heart                                              (50)         (35)         (33)         (50)                                   
      Cardiomyopathy, Chronic                         16 (32%)     10 (29%)     15 (45%)     23 (46%)                               
      Inflammation, Chronic Active                                               1 (3%)                                             
      Mineralization                                   1 (2%)                    1 (3%)                                             
      Atrium, Thrombosis                               4 (8%)       1 (3%)       2 (6%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (35)         (33)         (50)                                   
      Accessory Adrenal Cortical Nodule                2 (4%)                    1 (3%)       1 (2%)                                
      Atrophy                                          1 (2%)                                                                       
      Degeneration, Fatty                             24 (48%)     12 (34%)      7 (21%)     14 (28%)                               
      Hyperplasia                                     17 (34%)     10 (29%)      6 (18%)     17 (34%)                               
      Hypertrophy                                      1 (2%)                    1 (3%)       1 (2%)                                
      Karyomegaly                                                                1 (3%)       1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Necrosis                                         1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Pigmentation, Lipofuscin                         3 (6%)       2 (6%)       4 (12%)      7 (14%)                               
   Adrenal Medulla                                    (50)         (35)         (33)         (50)                                   
      Hyperplasia                                      9 (18%)      3 (9%)       1 (3%)       5 (10%)                               
   Islets, Pancreatic                                 (50)         (35)         (33)         (50)                                   
      Hyperplasia                                      1 (2%)                                 1 (2%)                                
   Parathyroid Gland                                  (48)         (32)         (31)         (45)                                   
      Hyperplasia                                      1 (2%)                    1 (3%)                                             
   Pituitary Gland                                    (50)         (35)         (33)         (50)                                   
      Angiectasis                                     36 (72%)     21 (60%)     19 (58%)     31 (62%)                               
      Mineralization                                   1 (2%)                    1 (3%)                                             
      Pigmentation, Hematoidin                         1 (2%)       1 (3%)                    1 (2%)                                
      Pars Distalis, Atypia Cellular                   1 (2%)                                                                       
      Pars Distalis, Cyst                             21 (42%)     11 (31%)     15 (45%)     29 (58%)                               
      Pars Distalis, Hyperplasia                       9 (18%)     11 (31%)      7 (21%)     17 (34%)                               
      Pars Distalis, Pigmentation, Hemosiderin        32 (64%)     20 (57%)     20 (61%)     31 (62%)                               
      Pars Distalis, Thrombosis                                     1 (3%)                                                          
      Pars Intermedia, Cyst                                         2 (6%)                    2 (4%)                                
   Thyroid Gland                                      (50)         (35)         (33)         (50)                                   
      Ultimobranchial Cyst                             1 (2%)                                                                       
      C-Cell, Hyperplasia                              7 (14%)      5 (14%)      5 (15%)      8 (16%)                               
      Follicle, Cyst                                                1 (3%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (49)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)       2 (4%)       1 (2%)      10 (20%)                               
      Inflammation, Chronic Active                     6 (12%)      4 (8%)       4 (8%)       7 (14%)                               
      Duct, Cyst                                       1 (2%)                    2 (4%)       2 (4%)                                
      Duct, Hyperplasia                                                          2 (4%)                                             
   Ovary                                              (50)         (35)         (33)         (50)                                   
      Cyst                                             3 (6%)       1 (3%)       2 (6%)       4 (8%)                                
      Inflammation, Chronic Active                                               1 (3%)                                             
      Interstitial Cell, Hyperplasia                                             2 (6%)                                             
   Uterus                                             (50)         (35)         (33)         (50)                                   
      Cyst                                             2 (4%)                    1 (3%)                                             
   Vagina                                             (1)          (1)          (1)                                                 
      Inflammation, Suppurative                                     1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (35)         (33)         (48)                                   
      Hyperplasia                                     19 (38%)      4 (11%)     12 (36%)     10 (21%)                               
      Inflammation, Granulomatous                                                             1 (2%)                                
   Lymph Node                                         (45)         (32)         (27)         (43)                                   
      Lumbar, Hyperplasia, Lymphoid                                                           1 (2%)                                
      Mediastinal, Hyperplasia, Plasma Cell                                                   1 (2%)                                
      Mediastinal, Pigmentation, Hemosiderin          44 (98%)     31 (97%)     27 (100%)    40 (93%)                               
      Pancreatic, Pigmentation, Hemosiderin            1 (2%)                                                                       
      Renal, Pigmentation, Hemosiderin                 1 (2%)                                                                       
   Lymph Node, Mandibular                             (50)         (35)         (33)         (50)                                   
      Pigmentation, Hemosiderin                        2 (4%)       5 (14%)      6 (18%)      4 (8%)                                
   Lymph Node, Mesenteric                             (49)         (35)         (33)         (48)                                   
      Ectasia                                          1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
   Spleen                                             (50)         (35)         (33)         (50)                                   
      Accessory Spleen                                 2 (4%)                                                                       
      Fibrosis                                         3 (6%)                                                                       
      Hematopoietic Cell Proliferation                 2 (4%)       4 (11%)      3 (9%)       1 (2%)                                
      Necrosis                                                      1 (3%)                                                          
      Pigmentation, Hemosiderin                        4 (8%)       5 (14%)      9 (27%)     11 (22%)                               
      Capsule, Fibrosis                                             1 (3%)                                                          
      Capsule, Inflammation, Chronic Active                         1 (3%)                                                          
      Lymphoid Follicle, Depletion Cellular                         1 (3%)                                                          
   Thymus                                             (49)         (35)         (31)         (49)                                   
      Cyst                                             1 (2%)       1 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (35)         (33)         (50)                                   
      Hyperplasia, Cystic                             42 (84%)     23 (66%)     27 (82%)     42 (84%)                               
      Duct, Cyst                                       1 (2%)                                 1 (2%)                                
   Skin                                               (50)         (50)         (50)         (50)                                   
      Hyperkeratosis                                                             1 (2%)                                             
      Hyperplasia, Basal Cell                                                    1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Epidermis, Hyperplasia                                                     1 (2%)                                             
      Epidermis, Ulcer                                                           1 (2%)                                             
      Epidermis, Skin, Site of Application, Exudate                                           2 (4%)                                
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperplasia                                  1 (2%)                    4 (8%)       5 (10%)                               
      Epidermis, Skin, Site of Application,                                                                                         
          Inflammation, Chronic Active                                                        1 (2%)                                
      Epidermis, Skin, Site of Application, Ulcer      1 (2%)                    2 (4%)       2 (4%)                                
      Sebaceous Gland, Skin, Site of Application,                                                                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
           Hyperplasia                                 2 (4%)                    2 (4%)       2 (4%)                                
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic Active                              1 (2%)                    2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (35)         (33)         (48)                                   
      Fibrous Osteodystrophy                           1 (2%)                    1 (3%)                                             
      Osteopetrosis                                    1 (2%)                    1 (3%)                                             
      Femur, Osteosclerosis                                         1 (3%)                    1 (2%)                                
      Femur, Tibia, Osteosclerosis                                                            1 (2%)                                
      Joint, Arthrosis                                                           1 (3%)                                             
      Joint, Tarsal, Arthrosis                                                   1 (3%)                                             
      Tibia, Fracture                                               1 (3%)                                                          
   Skeletal Muscle                                                 (1)                                                              
      Inflammation, Chronic Active                                  1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (35)         (33)         (50)                                   
      Hemorrhage, Acute                                1 (2%)                                 1 (2%)                                
      Hydrocephalus                                    8 (16%)      5 (14%)      3 (9%)       7 (14%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (35)         (33)         (50)                                   
      Congestion, Acute                               13 (26%)     14 (40%)      8 (24%)     16 (32%)                               
      Foreign Body                                                               1 (3%)                                             
      Inflammation, Chronic Active                     3 (6%)       2 (6%)       2 (6%)       4 (8%)                                
      Inflammation, Granulomatous                                                             2 (4%)                                
      Inflammation, Suppurative                        1 (2%)                                                                       
      Mineralization                                   1 (2%)                    1 (3%)                                             
      Pigmentation, Hemosiderin                                                  1 (3%)                                             
      Alveolar Epithelium, Hyperplasia                              1 (3%)                    4 (8%)                                
      Alveolus, Hemorrhage, Acute                                                1 (3%)                                             
      Alveolus, Infiltration Cellular, Histiocyte     32 (64%)     23 (66%)     20 (61%)     39 (78%)                               
      Interstitium, Inflammation, Chronic Active       9 (18%)      4 (11%)      2 (6%)       5 (10%)                               
   Nose                                               (50)         (35)         (33)         (50)                                   
      Inflammation, Chronic Active                     4 (8%)                    2 (6%)       6 (12%)                               
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
          Active                                       1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Suppurative    10 (20%)      3 (9%)       1 (3%)       6 (12%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (2)          (2)          (5)                                    
      Cornea, Inflammation, Suppurative                1 (33%)                                                                      
      Lens, Cataract                                   1 (33%)      2 (100%)     2 (100%)     3 (60%)                               
      Retina, Degeneration                             1 (33%)      1 (50%)      2 (100%)     4 (80%)                               
      Retina, Hemorrhage                                                                      1 (20%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (35)         (33)         (50)                                   
      Infarct                                                       1 (3%)                                                          
      Mineralization                                  10 (20%)     22 (63%)      7 (21%)     11 (22%)                               
      Nephropathy, Chronic                            44 (88%)     25 (71%)     27 (82%)     37 (74%)                               
      Pelvis, Transitional Epithelium, Hyperplasia                  1 (3%)                                                          
      Renal Tubule, Pigmentation, Hemosiderin                                    1 (3%)                                             
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                     15            8           19           10                                     
    Moribund Sacrifice                                28           25           22           30                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                 7           17            9           10                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (50)         (33)         (41)         (50)                                   
      Parasite Metazoan                                4 (8%)       1 (3%)       2 (5%)       3 (6%)                                
   Intestine Large, Rectum                            (50)         (33)         (41)         (49)                                   
      Parasite Metazoan                                             2 (6%)       1 (2%)       2 (4%)                                
   Intestine Large, Cecum                             (50)         (33)         (41)         (50)                                   
      Inflammation, Chronic Active                                  1 (3%)       2 (5%)       1 (2%)                                
      Ulcer                                                         1 (3%)       1 (2%)       1 (2%)                                
   Intestine Small, Duodenum                          (50)         (33)         (41)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)       1 (3%)                                                          
      Ulcer                                            1 (2%)       1 (3%)                                                          
   Intestine Small, Jejunum                           (50)         (33)         (41)         (50)                                   
      Diverticulum                                                               1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       1 (3%)                                                          
      Necrosis                                         1 (2%)                                                                       
      Ulcer                                                         1 (3%)                                                          
   Intestine Small, Ileum                             (50)         (33)         (41)         (50)                                   
      Inflammation, Chronic Active                                  2 (6%)                    1 (2%)                                
      Parasite Metazoan                                                                       1 (2%)                                
      Ulcer                                                                                   1 (2%)                                
   Liver                                              (50)         (45)         (47)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Basophilic Focus                                 3 (6%)                    3 (6%)       6 (12%)                               
      Clear Cell Focus                                 3 (6%)                                 1 (2%)                                
      Degeneration, Cystic                            12 (24%)      4 (9%)       8 (17%)      9 (18%)                               
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)                    2 (4%)                                
      Hepatodiaphragmatic Nodule                       6 (12%)      2 (4%)       3 (6%)       9 (18%)                               
      Inflammation, Chronic                           20 (40%)      9 (20%)     10 (21%)     16 (32%)                               
      Necrosis                                         8 (16%)      4 (9%)       4 (9%)       2 (4%)                                
      Pigmentation, Hemosiderin                                     1 (2%)                                                          
      Bile Duct, Hyperplasia                          43 (86%)     29 (64%)     32 (68%)     43 (86%)                               
      Central Vein, Thrombosis                                      1 (2%)                                                          
      Hepatocyte, Hyperplasia                          1 (2%)       1 (2%)                    2 (4%)                                
      Hepatocyte, Vacuolization Cytoplasmic           21 (42%)     11 (24%)     16 (34%)     20 (40%)                               
      Hepatocyte, Centrilobular, Degeneration,                                                                                      

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
           Fatty                                       2 (4%)       4 (9%)                                                          
      Hepatocyte, Centrilobular, Necrosis              1 (2%)       3 (7%)                                                          
   Mesentery                                          (8)          (7)          (9)          (8)                                    
      Mineralization                                   3 (38%)      1 (14%)      2 (22%)      2 (25%)                               
      Artery, Inflammation, Chronic Active                          1 (14%)                                                         
      Fat, Inflammation, Chronic Active                4 (50%)      3 (43%)      4 (44%)      2 (25%)                               
      Fat, Necrosis                                                              1 (11%)                                            
   Oral Mucosa                                        (2)          (1)          (3)          (6)                                    
      Gingival, Dysplasia                                                        1 (33%)                                            
      Gingival, Inflammation, Chronic Active           1 (50%)      1 (100%)     2 (67%)      4 (67%)                               
   Pancreas                                           (50)         (33)         (41)         (50)                                   
      Inflammation, Chronic Active                                               1 (2%)                                             
      Acinus, Atrophy                                 25 (50%)     13 (39%)     16 (39%)     13 (26%)                               
      Acinus, Hyperplasia                              3 (6%)                    2 (5%)       1 (2%)                                
      Artery, Inflammation, Chronic Active                                       2 (5%)                                             
   Stomach, Forestomach                               (50)         (33)         (41)         (50)                                   
      Cyst                                             1 (2%)                                 1 (2%)                                
      Inflammation, Chronic Active                    12 (24%)     11 (33%)     11 (27%)     13 (26%)                               
      Mineralization                                   1 (2%)                    2 (5%)                                             
      Perforation                                                                             1 (2%)                                
      Ulcer                                            8 (16%)     10 (30%)     10 (24%)     11 (22%)                               
      Epithelium, Hyperplasia                         17 (34%)     11 (33%)     10 (24%)     17 (34%)                               
   Stomach, Glandular                                 (50)         (33)         (41)         (50)                                   
      Inflammation, Chronic Active                     3 (6%)       4 (12%)                   1 (2%)                                
      Mineralization                                   9 (18%)      1 (3%)       5 (12%)      4 (8%)                                
      Necrosis                                                      1 (3%)       1 (2%)       2 (4%)                                
      Ulcer                                            2 (4%)       3 (9%)                    1 (2%)                                
      Epithelium, Erosion                              1 (2%)       4 (12%)      3 (7%)       2 (4%)                                
      Epithelium, Hyperplasia                                       1 (3%)                                                          
   Tongue                                                          (1)                                                              
      Cyst                                                          1 (100%)                                                        
   Tooth                                              (1)                                                                           
      Inflammation, Chronic Active                     1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (33)         (41)         (50)                                   
      Mineralization                                   8 (16%)                   5 (12%)      2 (4%)                                
      Thrombosis                                                                 1 (2%)                                             
   Heart                                              (50)         (33)         (41)         (50)                                   
      Cardiomyopathy, Chronic                         29 (58%)     21 (64%)     27 (66%)     28 (56%)                               
      Inflammation, Chronic Active                     1 (2%)       1 (3%)                    1 (2%)                                
      Mineralization                                   7 (14%)      1 (3%)       4 (10%)      1 (2%)                                
      Atrium, Thrombosis                               4 (8%)       6 (18%)      6 (15%)      8 (16%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (33)         (41)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                                 1 (2%)                                
      Atrophy                                                                    1 (2%)                                             
      Degeneration, Fatty                             34 (68%)     23 (70%)     29 (71%)     33 (66%)                               
      Hyperplasia                                     25 (50%)      6 (18%)     17 (41%)     17 (34%)                               
      Hypertrophy                                                   2 (6%)       1 (2%)                                             
      Necrosis                                                                                1 (2%)                                
   Adrenal Medulla                                    (50)         (33)         (41)         (50)                                   
      Hyperplasia                                     30 (60%)     10 (30%)     17 (41%)     25 (50%)                               
   Islets, Pancreatic                                 (50)         (33)         (41)         (50)                                   
      Hyperplasia                                                   2 (6%)       5 (12%)      1 (2%)                                
   Parathyroid Gland                                  (46)         (29)         (39)         (45)                                   
      Hyperplasia                                     13 (28%)      3 (10%)      8 (21%)      5 (11%)                               
   Pituitary Gland                                    (50)         (33)         (41)         (50)                                   
      Angiectasis                                     38 (76%)     26 (79%)     30 (73%)     35 (70%)                               
      Hemorrhage                                                    1 (3%)                                                          
      Mineralization                                   5 (10%)                   1 (2%)                                             
      Necrosis                                                      1 (3%)       1 (2%)                                             
      Pigmentation, Hematoidin                         2 (4%)       1 (3%)       1 (2%)                                             
      Pars Distalis, Atrophy                                                     1 (2%)                                             
      Pars Distalis, Cyst                              8 (16%)      5 (15%)     10 (24%)     14 (28%)                               
      Pars Distalis, Hyperplasia                      12 (24%)      5 (15%)      7 (17%)     17 (34%)                               
      Pars Distalis, Pigmentation, Hemosiderin        33 (66%)     20 (61%)     26 (63%)     35 (70%)                               
      Pars Distalis, Thrombosis                                     1 (3%)       1 (2%)                                             
      Pars Intermedia, Cyst                            2 (4%)       2 (6%)                    3 (6%)                                
      Pars Nervosa, Cyst                               1 (2%)                                                                       
   Thyroid Gland                                      (50)         (33)         (41)         (50)                                   
      C-Cell, Hyperplasia                              7 (14%)      8 (24%)      7 (17%)     12 (24%)                               
      Follicle, Cyst                                   2 (4%)                    1 (2%)       4 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                                            (1)          (2)                                    
      Inflammation, Chronic Active                                               1 (100%)     2 (100%)                              
   Epididymis                                         (50)         (33)         (41)         (50)                                   
      Atrophy                                         25 (50%)     10 (30%)     16 (39%)     25 (50%)                               
      Inflammation, Chronic Active                                  1 (3%)                                                          
      Mineralization                                   1 (2%)                    2 (5%)                                             
   Preputial Gland                                    (50)         (33)         (40)         (50)                                   
      Cyst                                                                                    2 (4%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   10                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Hyperplasia                                      1 (2%)       1 (3%)       1 (3%)       2 (4%)                                
      Inflammation, Chronic Active                    47 (94%)     27 (82%)     38 (95%)     46 (92%)                               
      Duct, Cyst                                       1 (2%)       1 (3%)       3 (8%)                                             
   Prostate                                           (50)         (33)         (41)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
      Cyst                                                                                    3 (6%)                                
      Inflammation, Chronic Active                    49 (98%)     32 (97%)     38 (93%)     47 (94%)                               
      Mineralization                                   1 (2%)                                                                       
   Seminal Vesicle                                    (50)         (33)         (41)         (50)                                   
      Atrophy                                          3 (6%)       7 (21%)     11 (27%)     13 (26%)                               
      Inflammation, Chronic Active                     2 (4%)       1 (3%)                                                          
      Mineralization                                   1 (2%)                                                                       
   Testes                                             (50)         (33)         (41)         (50)                                   
      Artery, Inflammation, Chronic                   10 (20%)      2 (6%)       8 (20%)      9 (18%)                               
      Germinal Epithelium, Atrophy                    20 (40%)      6 (18%)     19 (46%)     13 (26%)                               
      Interstitial Cell, Hyperplasia                  20 (40%)     13 (39%)     11 (27%)     14 (28%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (32)         (41)         (50)                                   
      Hyperplasia                                     25 (50%)     13 (41%)     16 (39%)     38 (76%)                               
   Lymph Node                                         (41)         (25)         (31)         (41)                                   
      Lumbar, Hyperplasia, Lymphoid                                 1 (4%)                                                          
      Mediastinal, Atrophy                                                                    1 (2%)                                
      Mediastinal, Ectasia                             1 (2%)                                                                       
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                1 (4%)                                                          
      Mediastinal, Pigmentation, Hemosiderin          37 (90%)     23 (92%)     27 (87%)     36 (88%)                               
      Renal, Ectasia                                                             2 (6%)       1 (2%)                                
      Renal, Erythrophagocytosis                                                              1 (2%)                                
      Renal, Pigmentation, Hemosiderin                                           1 (3%)       1 (2%)                                
   Lymph Node, Mesenteric                             (50)         (33)         (41)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
      Ectasia                                          1 (2%)       3 (9%)       2 (5%)       6 (12%)                               
      Inflammation, Granulomatous                                                             1 (2%)                                
   Spleen                                             (50)         (46)         (47)         (50)                                   
      Fibrosis                                         6 (12%)                   4 (9%)       8 (16%)                               
      Hematopoietic Cell Proliferation                12 (24%)      6 (13%)      7 (15%)     10 (20%)                               
      Pigmentation, Hemosiderin                        4 (8%)                    1 (2%)       4 (8%)                                
      Lymphoid Follicle, Depletion Cellular            1 (2%)                                                                       
      Red Pulp, Depletion Cellular                                                            2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   11                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (32)         (40)         (50)                                   
      Hyperplasia, Cystic                             42 (84%)     26 (81%)     35 (88%)     41 (82%)                               
      Inflammation, Chronic Active                                                            1 (2%)                                
      Duct, Cyst                                                    1 (3%)       3 (8%)       2 (4%)                                
   Skin                                               (50)         (50)         (50)         (50)                                   
      Hyperkeratosis                                                1 (2%)                                                          
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperplasia                                               1 (2%)       1 (2%)       2 (4%)                                
      Sebaceous Gland, Skin, Site of Application,                                                                                   
           Hyperplasia                                 1 (2%)       1 (2%)                                                          
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic Active                                           1 (2%)                                                          
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (32)         (41)         (50)                                   
      Fibrous Osteodystrophy                          10 (20%)      1 (3%)       9 (22%)      8 (16%)                               
      Femur, Osteosclerosis                                                                   1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (33)         (41)         (50)                                   
      Hemorrhage, Acute                                             1 (3%)                    4 (8%)                                
      Hydrocephalus                                   11 (22%)     12 (36%)      9 (22%)      5 (10%)                               
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
   Spinal Cord                                        (1)          (1)          (1)                                                 
      Axon, Degeneration                               1 (100%)                  1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (33)         (41)         (50)                                   
      Congestion, Acute                               10 (20%)      9 (27%)     17 (41%)      6 (12%)                               
      Inflammation, Chronic Active                     3 (6%)       1 (3%)       2 (5%)       3 (6%)                                
      Inflammation, Granulomatous                      2 (4%)                    1 (2%)                                             
      Inflammation, Suppurative                                                  1 (2%)       1 (2%)                                
      Mineralization                                   7 (14%)                   5 (12%)                                            
      Necrosis                                                                   1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 3 (6%)       2 (6%)       1 (2%)       3 (6%)                                
      Alveolus, Hemorrhage, Acute                      3 (6%)       1 (3%)       1 (2%)                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   12                                                              
NTP Experiment-Test: 05188-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 04:28:15  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      60 MG/KG     120          240                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Alveolus, Infiltration Cellular, Histiocyte     24 (48%)     10 (30%)     16 (39%)     16 (32%)                               
      Interstitium, Inflammation, Chronic Active       7 (14%)                   4 (10%)      3 (6%)                                
   Nose                                               (50)         (32)         (41)         (50)                                   
      Inflammation, Chronic Active                     5 (10%)      8 (25%)      4 (10%)      5 (10%)                               
      Polyp Inflammatory                               1 (2%)                                                                       
      Thrombosis                                                    1 (3%)       1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Suppurative     5 (10%)      3 (9%)       3 (7%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (2)          (2)          (1)                                    
      Anterior Chamber, Hemorrhage, Acute              1 (33%)                                                                      
      Cornea, Inflammation, Suppurative                1 (33%)                                                                      
      Lens, Cataract                                   2 (67%)      1 (50%)      1 (50%)      1 (100%)                              
      Retina, Degeneration                             2 (67%)      2 (100%)     1 (50%)      1 (100%)                              
   Harderian Gland                                    (1)          (1)                       (1)                                    
      Inflammation, Chronic                            1 (100%)     1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (33)         (41)         (50)                                   
      Accumulation, Hyaline Droplet                                              1 (2%)                                             
      Infarct                                                                                 2 (4%)                                
      Mineralization                                   4 (8%)       3 (9%)       2 (5%)       1 (2%)                                
      Nephropathy, Chronic                            50 (100%)    32 (97%)     41 (100%)    50 (100%)                              
      Cortex, Cyst                                     8 (16%)      1 (3%)       1 (2%)      10 (20%)                               
   Urinary Bladder                                    (50)         (33)         (41)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   13                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------